Bristol-Myers Squibb Company vs Novo Nordisk
Comparaison de la capitalisation boursière au fil du temps
Bristol-Myers Squibb Company
$132.0B
Rang #127
Novo Nordisk
$140.2B
Rang #122
Capitalisation boursière au fil du temps
Moments clés
- Novo Nordisk a dépassé Bristol-Myers Squibb Company avant 2010
- Bristol-Myers Squibb Company a dépassé Novo Nordisk avant 2011
- Novo Nordisk a dépassé Bristol-Myers Squibb Company avant 2021
Comparaison année par année
| Année | Bristol-Myers Squibb Company | Novo Nordisk | Leader |
|---|---|---|---|
| 2026 | $132.0B | $140.2B | Novo Nordisk |
| 2025 | $107.8B | $152.9B | Novo Nordisk |
| 2024 | $107.6B | $285.3B | Novo Nordisk |
| 2023 | $92.9B | $315.6B | Novo Nordisk |
| 2022 | $125.8B | $209.4B | Novo Nordisk |
| 2021 | $105.8B | $161.6B | Novo Nordisk |
| 2020 | $102.0B | $92.0B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $81.6B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $61.4B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $67.2B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $49.6B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $75.8B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $48.6B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $36.5B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $33.0B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $23.3B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $43.8B | Novo Nordisk |
| 2009 | $28.9B | $22.7B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $9.1B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $22.1B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $7.7B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $5.7B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $9.4B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $7.5B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $6.2B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $10.3B | Bristol-Myers Squibb Company |